CJC-1295 (5MG)

$55.00

CJC-1295 is a synthetic GHRH analog widely referenced in scientific literature for studies involving endocrine signaling and peptide–receptor interactions. Each vial undergoes third-party analytical testing to confirm identity and purity for laboratory research use.

CJC-1295 Peptide

CJC-1295 is a synthetic growth hormone–releasing hormone (GHRH) analog frequently referenced in scientific literature for its relevance in endocrine signaling and peptide–receptor interaction studies. Researchers commonly investigate CJC-1295 within laboratory models evaluating growth hormone regulatory pathways and hypothalamic–pituitary signaling mechanisms.

This research peptide is supplied as a lyophilized vial and undergoes third-party analytical testing to confirm identity and purity prior to distribution.


Specifications

• Peptide: CJC-1295

• Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2

• Form: Lyophilized Research Peptide Vial

• Purity: ≥ 98% (HPLC Verified)

• Molecular Weight: 3367.9 g/mol

• Storage: Store in a cool, dry environment away from direct light

• Intended Use: Laboratory research and analytical reference only

Certificate of Analysis

Each Hawthorne Research compound is supported by batch-specific analytical documentation verifying identity, composition, and purity through standardized laboratory testing.

Analytical Verification

  • Identity confirmation using validated analytical methods
  • Purity and chromatographic profile verification
  • Content and concentration alignment
  • Key quality parameters evaluated prior to release
  • Lot-level traceability and documentation